全文获取类型
收费全文 | 641篇 |
免费 | 90篇 |
国内免费 | 8篇 |
专业分类
耳鼻咽喉 | 3篇 |
儿科学 | 52篇 |
妇产科学 | 13篇 |
基础医学 | 81篇 |
口腔科学 | 6篇 |
临床医学 | 60篇 |
内科学 | 191篇 |
皮肤病学 | 11篇 |
神经病学 | 68篇 |
特种医学 | 48篇 |
外科学 | 39篇 |
综合类 | 20篇 |
预防医学 | 29篇 |
眼科学 | 35篇 |
药学 | 18篇 |
中国医学 | 1篇 |
肿瘤学 | 64篇 |
出版年
2022年 | 5篇 |
2021年 | 4篇 |
2020年 | 10篇 |
2019年 | 12篇 |
2018年 | 8篇 |
2017年 | 15篇 |
2016年 | 12篇 |
2015年 | 11篇 |
2014年 | 12篇 |
2013年 | 14篇 |
2012年 | 16篇 |
2011年 | 23篇 |
2010年 | 19篇 |
2009年 | 12篇 |
2008年 | 24篇 |
2007年 | 27篇 |
2006年 | 18篇 |
2005年 | 18篇 |
2004年 | 25篇 |
2003年 | 23篇 |
2002年 | 17篇 |
2001年 | 24篇 |
2000年 | 19篇 |
1999年 | 22篇 |
1998年 | 17篇 |
1997年 | 11篇 |
1996年 | 16篇 |
1995年 | 10篇 |
1994年 | 18篇 |
1993年 | 8篇 |
1992年 | 16篇 |
1991年 | 12篇 |
1990年 | 10篇 |
1989年 | 15篇 |
1988年 | 12篇 |
1987年 | 22篇 |
1986年 | 18篇 |
1985年 | 24篇 |
1984年 | 10篇 |
1983年 | 11篇 |
1982年 | 16篇 |
1981年 | 14篇 |
1980年 | 9篇 |
1979年 | 23篇 |
1978年 | 12篇 |
1977年 | 8篇 |
1976年 | 10篇 |
1975年 | 4篇 |
1972年 | 4篇 |
1970年 | 3篇 |
排序方式: 共有739条查询结果,搜索用时 203 毫秒
1.
2.
Benign intracranial hypertension and recombinant growth hormone therapy in Australia and New Zealand
PA Crock JD McKenzie AM Nicoll NJ Howard W Cutfield LK Shield G Byrne 《Acta paediatrica (Oslo, Norway : 1992)》1998,87(4):381-386
Benign intracranial hypertension (BIH) is reported in three children from Australia and one from New Zealand, who were being treated with recombinant human growth hormone (rhGH). Three males and one female, aged between 10.5 and 14.2 y, developed intracranial hypertension within 2 weeks to 3 months of starting treatment. A national database, OZGROW, has been prospectively collecting data on all 3332 children treated with rhGH in Australia and New Zealand from January 1986 to 1996. The incidence of BIH in children treated with growth hormone (GH) is small, 1.2 per 1000 cases overall, but appears to be greater with biochemical GHD (<10IUml -1 ), i.e. 6.5/1000 (3 in 465 cases), relative risk 18.4, 95% confidence interval 1.9-176.1, than in all other children on the database. The incidence in patients with Turner's syndrome was 2.3/1000 (1 in 428 cases). No cases in patients with partial GHD (10–20 IUml -1 ) or chronic renal failure were identified. Possible causative mechanisms are discussed. The authors'practice is now to start GH replacement at less than the usual recommended dose of 14IUm-2 week-1 in those children considered to be at high risk of developing BIH. Ophthalmological evaluation is recommended for children before and during the first few months following commencement of rhGH therapy and is mandatory in the event of peripheral or facial oedema, persistent headaches, vomiting or visual symptoms. The absence of papilledema does not exclude the diagnosis. 相似文献
3.
4.
5.
6.
7.
D I Boxer 《The British journal of radiology》1988,61(723):267-268
8.
3-Carboxy-3,4-dehydropyrrolidine was found to bind with affinity equal to that of glycine in a [3H]strychnine binding assay. Simple substitution of the 1-, 2-, 4-, or 5-position resulted in marked loss of affinity. A decline in affinity was also found upon enlargement, contraction, or saturation of the 5-membered ring. However, beta-proline and azetidine-3-carboxylic acid retained significant binding affinity. Despite its good affinity in [3H]strychnine binding, 3-carboxy-3,4-dehydropyrrolidine showed only weak agonist activity in intracellular recordings of cultured murine spinal cord neurons. This apparent lack of correlation between binding and functional results is discussed in light of the current models of the strychnine-sensitive glycine receptor. 相似文献
9.
10.
Life expectancy in British Marfan syndrome populations 总被引:2,自引:0,他引:2
JR Gray AB Bridges RR West L. McLeish AG Stuart JCS Dean MEM Porteous M. Boxer SJ Davies 《Clinical genetics》1998,54(2):124-128
A total of 206 patients with Marfan syndrome were ascertained throughout genetic clinics in Wales and Scotland during the period 1970–1990. There were 45 deaths representing 22% of the cohort. Mean age at death was 45.3 ± 16.5 years. 50% median cumulative survival in the total cohort (n = 206) was 53 years for males and 72 years for females. Multivariate analysis confirmed severity as the best independent indicator of survival. These findings and survival curves will assist in the counselling of British families and individuals with Marfan syndrome. 相似文献